Intake of Marine ω-3 PUFAs Tied to Colorectal Cancer Survival

This article originally appeared here.
Share this content:
Intake of Marine ω-3 PUFAs Tied to Colorectal Cancer Survival
Intake of Marine ω-3 PUFAs Tied to Colorectal Cancer Survival

FRIDAY, July 22, 2016 (HealthDay News) -- Colorectal cancer (CRC) patients who consume higher amounts of omega-3 polyunsaturated fatty acids (PUFAs), mainly from oily fish, may have better odds of survival, according to a study published online July 19 in Gut.

Andrew Chan, M.D., of Massachusetts General Hospital in Boston, and colleagues tracked data on 1,659 patients diagnosed with CRC. During an average follow-up of about 10 years, 561 of the patients died. CRC was the cause of death in 169 cases, while other major causes of death included cardiovascular disease (153 cases) and other types of cancer (113 cases).

The researchers found that patients who consumed at least 0.3 g of omega-3 PUFAs per day after their CRC diagnosis were 41 percent less likely to die of the disease than those who consumed less than 0.1 g per day. The reduced risk was associated with omega-3 PUFAs from both food and fish oil supplements, but few of the patients used supplements, the researchers noted. The link between marine omega-3 PUFAs and lower risk of death from CRC was particularly strong for patients who were taller, relatively thin, and did not take aspirin regularly.

The researchers found that increasing intake of omega-3 PUFAs by at least 0.15 g per day after a CRC diagnosis was associated with a 70 percent lower risk of dying from the disease, while a reduction in daily intake was associated with a 10 percent higher risk of death from the disease. The all-cause mortality risk was also 13 percent lower in those who increased their intake of omega-3 PUFAs, but 21 percent higher among those who decreased their intake.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Opioid Rx, Dosing Often Excessive in Dialysis Patients

Opioid Rx, Dosing Often Excessive in Dialysis Patients

High-risk dialysis population also subject to the risks of long-term opioid use

Nonadherence to Statins  ACEIs/ARBs Risky Post MI

Nonadherence to Statins + ACEIs/ARBs Risky Post MI

Adherence to beta-blockers may not be as beneficial to patients after myocardial infarction

Pulse Ox  Auscultation Reliable for Congenital Heart Screening

Pulse Ox + Auscultation Reliable for Congenital Heart ...

The method significantly improves detection rate of major CHD in newborns

is free, fast, and customized just for you!

Already a member?

Sign In Now »